Jul 1, 2020
Seth Lederman, MD, Chief Executive Officer and Founder, Tonix Pharmaceuticals brings us up to speed on the work at Tonix in developing new COVID-19 vaccines based on their live, synthetic horsepox vector system with a focus on vaccinating the subgroup of healthy people who are not pregnant and have a working immune system. Seth talks about the advantages of using live replicating virus vaccines as well as how immuno-oncology is informing their approach to stimulating T-cells to fight infectious diseases. In addition, new medicines are being developed to treat fibromyalgia and PTSD.
#COVID19 #vaccines #PTSD #fibromyalgia #pain